Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Apply
Vibegron
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step